JNJ-AbbVie cancer drug Imbruvica succeeds in late-stage trial
FILE PHOTO: The Johnson and Johnson logo is seen at an office building in Singapore January 17, 2018. REUTERS/Thomas White (Reuters) – Johnson and Johnson said on Tuesday a combination…
Unilever CEO retires after headquarters row, replaced by insider Jope
LONDON (Reuters) – Unilever’s (ULVR.L) Chief Executive Paul Polman will step down next month after 10 years in the job, leaving insider Alan Jope to step into his shoes after…
United Technologies to separate into three companies
(Reuters) – United Technologies Corp (UTX.N) said on Monday it would separate into three companies consisting of its aerospace, elevators and building divisions, making it the latest industrial conglomerate to…
U.S. regulators snip red tape for medical devices to curb opioid crisis
(Reuters) – Laura Perryman expected her medical company, Stimwave Technologies Inc, would have to wait several years for its painkilling device to win U.S. approval as a treatment for chronic…
Disney tops profit targets as fans flock to parks, movies
(Reuters) – Walt Disney Co (DIS.N) reported a quarterly profit that topped Wall Street estimates on Thursday, driven by summer crowds at the company’s theme parks and big audiences for…
Elon Musk says deleted his Tesla titles
(Reuters) – Tesla Inc (TSLA.O) Chief Executive Officer Elon Musk took to Twitter on Monday, saying he deleted his Tesla titles last week to see what would happen, without giving…
Alphabet misses Wall Street revenue estimates; shares fall
(Reuters) – Google parent Alphabet Inc (GOOGL.O) on Thursday missed analysts’ quarterly revenue estimates for the first time in at least two years and reported continuing erosion of its operating…
Fiat Chrysler agrees to sell Magneti Marelli to Calsonic Kansei: sources
MILAN/LONDON (Reuters) – Fiat Chrysler (FCHA.MI) (FCA) has agreed to sell its Magneti Marelli unit to KKR’s (KKR.N) Calsonic Kansei, two sources familiar with the matter said on Sunday, adding…
Sanofi drug Dupixent wins FDA approval to treat asthma
(Reuters) – France’s Sanofi SA said on Friday eczema drug Dupixent was approved by the U.S. Food and Drug Administration as an additional maintenance therapy in patients with two types…
AbbVie CFO Chase stepping down, to retire by mid-year 2019
(Reuters) – AbbVie Inc (ABBV.N) said on Friday that Chief Financial Officer William Chase is retiring in mid-2019 and named its controller, Robert Michael, his immediate successor as CFO. FILE…